SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

Report abuse about a comment

Further comment on dubious study

As I stated a week ago in response to the recently released study on resveratrol, the fault here is with the study design and protocol itself, not the resveratrol used in the study. The dosage used in this study was ridiculously low, compared to all earlier studies. In the case of the successful Albert Einstein Medical School study and the more recent Florida Pharmacology School study the dosages were approximately 10 to 20 times this amount. This dosage is consistent with the supplements used in those trials, specifically biotivia transmax and bioforte, which are readily available without a prescription. Using a dosage of only 75mg was tantamount to giving a heart attack victim one aspirin.

In all previous studies on actual type 2 diabetic patients or those suffering impaired glucose tolerance, a sign of impending diabetes, resveratrol was extremely effective in improving glucose tolerance, enhancing metabolic function and blocking the onset of diabetes.

As a cell biologist who has been involved in several human clinical trials of transmax and bioforte resveratrol against diabetes, I can only imagine that this study was designed by a pharmaceutical company to fail intentionally. The pharmas are clearly aware of the potential of resveratrol to cut into their sales of Metformin, a multi-billion dollar earner for the drug companies, and are on a campaign to discredit the compound.

As a researcher I question why the clinicians in this study would select as subjects women who have no issues with glucose tolerance, who were non-obese, and who did not exhibit signs of diabetes. This is equivalent to testing a compound designed to treat cancer on a group of subjects none of whom has cancer. Again, we see a troubling signal of possible pharma involvement.

Posted by James Betz
01 November 2012 | 08h40

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Resveratrol study results don’t tell the whole story on benefits: Expert

Spotlight

Calcium, vitamin D supplementation for women at risk of osteoporosis

Combating osteoporosis with calcium, vitamin D could save as much as $12 billion by 2020, CRN says

Supplementation with calcium and vitamin D for postmenopausal women could save the US health care system as...

CSPI asks FDA to ban powdered caffeine sold as a dietary supplement

CSPI asks FDA to ban powdered caffeine sold as a dietary supplement

The Center for Science in the Public Interest (CSPI) has sent a petition to federal regulators seeking...

Polyphenol-enriched protein powder shows immune benefits for athletes: Study

Polyphenol-enriched protein powder shows immune benefits for athletes: Study

A soy protein powder enriched with blueberry and green tea polyphenols may reduce exercise-induced susceptibility to viral...

DASCA heads to the White House for President’s signature
CRN hails passage of bill as ‘welcome protection against criminal outliers’

DASCA heads to the White House for President’s signature

The Designer Anabolic Steroid Control Act has passed Congress and will now be sent to the President’s...

Micronutrient insufficiencies: ‘The DGAC is turning a blind eye to this problem because they are preaching an ideal’

Micronutrient insufficiencies: ‘The DGAC is turning a blind eye to this problem because they are preaching an ideal’

The majority of Americans are not meeting the requirements for a number of essential nutrients, but the...

Overall FDA's 483 observations are down, but basic GMP failures still rampant, consultant finds

Overall FDA's 483 observations are down, but basic GMP failures still rampant, consultant finds

Preliminary data from consultant Marian Boardley, who tracks trends in FDA inspection reports, shows that overall 483...

DSHEA, the media, & certifying manufacturers: Highlights from the NIU's Business Leaders Forum, Part 1

DSHEA, the media, & certifying manufacturers: Highlights from the NIU's Business Leaders Forum, Part 1

The dietary supplements industry needs to engage with journalists to change the conversation and not run ad...

Innovation, retailer shifts, and sustainability: Highlights from NIU’s Business Leaders Forum, Part 2

Innovation, retailer shifts, and sustainability: Highlights from NIU’s Business Leaders Forum, Part 2

The lack of clarity over the new dietary ingredient (NDI) guidance is stifling innovation in dietary supplements,...

NOI urges FDA to end attempts to regulate dietary supplements as food additives
Hearing on potential changes to Redbook to take place tomorrow

NOI urges FDA to end attempts to regulate dietary supplements as food additives

The Food and Drug Administration should finalize the revised draft guidance for New Dietary Ingredients (NDIs) and...

‘Impacting industry in a meaningful way’: NPA and UL announce education alliance for GMPs, claims and more

‘Impacting industry in a meaningful way’: NPA and UL announce education alliance for GMPs, claims and more

The Natural Products Association (NPA) and UL are partnering on a new education alliance to ‘raise the...

Key Industry Events

 

Access all events listing

Our events, Events from partners...